ID
29114
Description
Study ID: 101468/249 Clinical Study ID: 101468/249 Study Title: A 12-Week, Double-Blind, Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00363857 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: N/A Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Restless Legs Syndrome; Restless Legs Syndrome (RLS)
Keywords
Versions (1)
- 2/26/18 2/26/18 -
Copyright Holder
GlaxoSmithKline (GSK)
Uploaded on
February 26, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Clinical Study, Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS), Study ID: 101468/249, NCT00363857
Study medication and compliance record
- StudyEvent: ODM
Description
Study medication
Alias
- UMLS CUI-1
- C0013227
- UMLS CUI-2
- C0304229
- UMLS CUI-3
- C0008976
- UMLS CUI-4
- C0035258
Description
Study Medication Week No.
Data type
integer
Alias
- UMLS CUI [1]
- C0439230
Description
If ’Yes’, please complete the Dose Reductions due to AE on page 95. Do not continue on this page for this visit.
Data type
boolean
Alias
- UMLS CUI [1]
- C1707814
Description
Dose level
Data type
integer
Alias
- UMLS CUI [1]
- C0178602
Description
Date of first dose
Data type
date
Alias
- UMLS CUI [1]
- C3173309
Description
Date of last dose
Data type
date
Alias
- UMLS CUI [1]
- C1762893
Description
Number of tablets dispensed
Data type
integer
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0039225
Description
Number of tablets returned
Data type
integer
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0039225
Description
Interruption
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1512900
Description
Dose Reduction due to adverse experiences
Alias
- UMLS CUI-1
- C1707814
- UMLS CUI-2
- C0559546
Description
Study Med. Week No.
Data type
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0439230
Description
Dose level
Data type
integer
Alias
- UMLS CUI [1]
- C0178602
Description
Date of first dose
Data type
date
Alias
- UMLS CUI [1]
- C3173309
Description
Date of last dose
Data type
date
Alias
- UMLS CUI [1]
- C1762893
Description
Number of tablets dispensed
Data type
integer
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0039225
Description
Number of tablets returned
Data type
integer
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0039225
Description
Interruption
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1512900
Description
Study Med. Week No.
Data type
integer
Alias
- UMLS CUI [1]
- C0439230
Description
Medication Label
Data type
text
Alias
- UMLS CUI [1]
- C0013227
Description
Medication Labels
Alias
- UMLS CUI-1
- C0013227
Description
Study Med. Week No.
Data type
integer
Alias
- UMLS CUI [1]
- C0439230
Description
Medication Label
Data type
text
Alias
- UMLS CUI [1]
- C0013227
Similar models
Study medication and compliance record
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0304229 (UMLS CUI-2)
C0008976 (UMLS CUI-3)
C0035258 (UMLS CUI-4)
C0039225 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,2])
C1512900 (UMLS CUI [1,2])
C0559546 (UMLS CUI-2)
C0439230 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,2])
C1512900 (UMLS CUI [1,2])